These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33446110)

  • 21. Target Doses of Secondary Prevention Medications Are Not Being Achieved in Patients With Reduced Left Ventricular Ejection Fraction After Acute Coronary Syndrome (ANZACS-QI 34).
    Chan D; Doughty RN; Lund M; Lee M; Kerr AJ
    Heart Lung Circ; 2020 Sep; 29(9):1386-1396. PubMed ID: 32423781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of β-blocker therapy for long-term outcomes in patients with low ejection fraction after cardiac surgery.
    Fan FD; Zhang HT; Pan T; Tang XL; Wang DJ
    BMC Cardiovasc Disord; 2020 Aug; 20(1):379. PubMed ID: 32819270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of
    Chen Y; Tang XF; Gao RL; Yang YJ; Xu B; Yuan JQ
    Cardiovasc Ther; 2020; 2020():4351469. PubMed ID: 32405323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
    Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.
    Kiès P; Boersma E; Bax JJ; van der Burg AE; Bootsma M; van Erven L; van der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1049-56. PubMed ID: 16191114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis.
    Misumida N; Harjai K; Kernis S; Kanei Y
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):280-5. PubMed ID: 26424094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-Blockers and Cardiovascular Outcomes in Acute Heart Failure with a History of Coronary Artery Disease and an Ejection Fraction ≥ 40.
    Abi Khalil C; Sulaiman K; Asaad N; AlHabib KF; Alsheikh-Ali A; Jameesh M; Al-Jarallah M; Bulbanat B; AlMahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; AlFaleh H; Panduranga P; Mahfoud Z; Al Suwaidi J
    Curr Vasc Pharmacol; 2020; 18(6):644-651. PubMed ID: 31889498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-blockers for post-acute coronary syndrome mid-range ejection fraction: a nationwide retrospective study.
    Montenegro Sá F; Carvalho R; Ruivo C; Santos LG; Antunes A; Soares F; Belo A; Morais J;
    Eur Heart J Acute Cardiovasc Care; 2019 Oct; 8(7):599-605. PubMed ID: 30714389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
    Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial Strain for Identification of β-Blocker Responders in Heart Failure with Preserved Ejection Fraction.
    Park JJ; Choi HM; Hwang IC; Park JB; Park JH; Cho GY
    J Am Soc Echocardiogr; 2019 Nov; 32(11):1462-1469.e8. PubMed ID: 31540679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization: a meta-analysis of adjusted results.
    Peyracchia M; Errigo D; Raposeiras Rubin S; Conrotto F; DiNicolantonio JJ; Omedè P; Rettegno S; Iannaccone M; Moretti C; D'Amico M; Gaita F; D'Ascenzo F
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):337-343. PubMed ID: 29877974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
    Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
    Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical profile and causes of death according to ejection fraction in patients with heart failure cared for in a specialized Cardiology unit.
    Barge-Caballero E; Montero-Fole B; Barge-Caballero G; Couto-Mallón D; Paniagua-Martín MJ; Pardo-Martínez P; Sagastagoitia-Fornie M; Muñiz J; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Rev Clin Esp (Barc); 2022 Mar; 222(3):152-160. PubMed ID: 35227424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Russo JJ; Prasad M; Doshi D; Karmpaliotis D; Parikh MA; Ali ZA; Popma JJ; Pershad A; Ohman EM; Douglas PS; O'Neill WW; Leon MB; Moses JW; Kirtane AJ
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):764-770. PubMed ID: 31693292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative beta-blocker in ventricular dysfunction patients: need a more granular quality metric.
    Tang H; Chen K; Hou J; Huang X; Liu S; Hu S
    BMC Cardiovasc Disord; 2021 Nov; 21(1):552. PubMed ID: 34798823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Captopril adjuvant therapy to beta-blockers and nitrates improves post-myocardial infarction left ventricular performance.
    Kyriakidis M; Antonopoulos A; Georgiou E; Santas P; Bakirtzis C; Toutouzas P
    Eur Heart J; 1996 Jun; 17(6):864-73. PubMed ID: 8781825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study.
    Gu J; Fan YQ; Bian L; Zhang HL; Xu ZJ; Zhang Y; Chen QZ; Yin ZF; Xie YS; Wang CQ
    Eur J Prev Cardiol; 2016 Sep; 23(13):1421-8. PubMed ID: 26915580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study.
    Wen XS; Luo R; Liu J; Duan Q; Qin S; Xiao J; Zhang DY
    BMC Cardiovasc Disord; 2022 Apr; 22(1):193. PubMed ID: 35473676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.
    Kotecha D; Gill SK; Flather MD; Holmes J; Packer M; Rosano G; Böhm M; McMurray JJV; Wikstrand J; Anker SD; van Veldhuisen DJ; Manzano L; von Lueder TG; Rigby AS; Andersson B; Kjekshus J; Wedel H; Ruschitzka F; Cleland JGF; Damman K; Redon J; Coats AJS;
    J Am Coll Cardiol; 2019 Dec; 74(23):2893-2904. PubMed ID: 31806133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.